Drunk driving is one of the largest social problems related to alcohol use. Driving under the influence (DUI) of alcohol is involved in 40–45% of all fatal traffic accidents. As a result, legislators, educators, and law enforcement officers are continually attempting to find ways to prevent driving under the influence
Drunk driving is one of the largest social problems related to alcohol use. Driving under the influence (DUI) of alcohol is involved in 40–45% of all fatal traffic accidents. As a result, legislators, educators, and law enforcement officers are continually attempting to find ways to prevent driving under the influence of alcohol.
Select one of the following age groups: teens (13–17 years), college-age (18–25 years), adults (26–60 years), or seniors (61 years and up).
For your selected age group, develop a plan to reduce driving under the influence. The plan could include (but not be limited to) educational, legislative, and community support; and social advertising. Present at least three action points in your plan. Be sure to include:
Get Answer Now
The format of the plan
Who will deliver the information and how
Specific tactics used to target the selected group
Methods used to measure the success of the plan
Be sure to include an introduction and summary for your plan. Support your recommendations using authoritative sources.
Write a 2–3-page plan in Word format. Apply APA standards to citation of sources.
Get Answer Now
Order This Solution
49051 Millions developed by 10% and working benefit in 2009 was 15012 Millions that developed by 6%. Roche is contributed CHF. 9874 Millions on R&D in 2009. The free trade stream out 2009 was 8893 that was 79% more than 2008. The aggregate representative of Roche are 81507. Out of them 80115 are changeless. The Sales commitment is more from US that is 38% than West Europe that is 28%. Since pharmaceutical advertising exercises impact the endorsing conduct of specialists, it is of most extreme significance to basically dissect the cases made in the limited time material of the medications. The degree to which pharmaceutical organizations advance the benefits of their items and applicable clinical trails give to specialists are not examined in Pakistan. The consequences of the present logical examination demonstrate that untrustworthy and one-sided claims with respect to the pharmaceutical items are uncontrolled in Pakistan. These medication advancements impact the recommending conduct of the General Practitioners, Consultants in this manner representing one of the possibly significant reasons for outlandish solution. Roche Pakistan Ltd is a Member of IFPMA and PMA and take after their moral business rules to offer its items. Roche Paksitan Ltd is at sixth positioning in Pakistan Pharmaceutical Market and its yearly deal is Rs. 5.2 Billions out of 2009 in Pakistan.>GET ANSWER